Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Current Opinion in Infectious Diseases|November 1, 2016
How recent findings on the pharmacokinetics and pharmacodynamics of integrase inhibitors can inform clinical useEmilie Elliot, Mimie Chirwa, Marta BoffitoThe Journal of Antimicrobial Chemotherapy|December 19, 2015
Dolutegravir and elvitegravir plasma concentrations following cessation of drug intakeEmilie Elliot, Alieu Amara, Akil Jackson, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|June 13, 2016
The development and application of a novel LC-MS/MS method for the measurement of Dolutegravir, Elvitegravir and Cobicistat in human plasmaSujan Dilly Penchala, Sandra Fawcett, Laura Else, et al.Therapeutic Advances in Infectious Disease|December 18, 2023
Practical dosing guidance for the management of clinician-administered injections of long-acting cabotegravir and rilpivirineParul Patel, Paula Teichner, Emilie Elliot, et al.Open Forum Infectious Diseases|June 17, 2024
Cabotegravir + Rilpivirine Long-Acting: Overview of Injection Guidance, Injection Site Reactions, and Best Practices for Intramuscular Injection AdministrationPaula Teichner, Nadine Chamay, Emilie Elliot, et al.Pageof 1